Coloplast (Coloplast Manufacturing France)
↗Sarlat-La-Caneda, France (subsidiary); Humlebæk, Denmark (parent company)
Coloplast Manufacturing France SAS is a manufacturing subsidiary of Coloplast A/S, a leading Danish multinational medical device company founded in 1957. The French subsidiary, established in 1986, is located in Sarlat-La-Caneda in the Nouvelle-Aquitaine region and specializes in the production of medical devices for urology and surgery. Coloplast develops, manufactures, and markets innovative solutions for intimate healthcare needs, serving over 2 million patients globally. The company operates through six main business segments: Ostomy Care, Continence Care, Voice & Respiratory Care (via Atos Medical acquisition), Interventional Urology, and Advanced Wound Care with biologics (via Kerecis acquisition), employing over 16,000 people worldwide across manufacturing facilities in Denmark, Hungary, France, China, and the United States. The France facility employs approximately 250 people and generated €77.8 million in turnover as of September 2024.
CLASSIFICATION
Company Type:MedTech
Therapeutic Areas:-
Industry:Medical Devices
Sub-Industry:Ostomy care, Continence care, Wound care, Interventional urology, Respiratory care
SIZE & FINANCIALS
Employees:10001-5000
Revenue:$3.96B - $4.12B (global)
Founded:1986
Ownership:subsidiary
Status:operating
STOCK
Exchange:Nasdaq Copenhagen / NASDAQ
Ticker:COLO B (Nasdaq Copenhagen), CLPBY (NASDAQ ADR), CLPBF (OTC)
Market Cap:$21B
PIPELINE
Stage:Commercial|Clinical
Lead Drug Stage:INTIBIA (Phase 3 pivotal trial)
Modalities:Medical devices, Ostomy pouches, Catheters, Surgical slings, Implants, Advanced wound dressings, Fish-skin biologics, Implantable tibial nerve stimulators
Active Trials:8
Trial Phases:Phase 2: 1 | Phase 3: 2 | Phase 4: 5
FDA Approvals:50
EMA Approvals:25
CORPORATE STRUCTURE
Parent Company:Coloplast A/S
Subsidiaries:Atos Medical (Voice & Respiratory Care), Kerecis (Advanced Wound Care Biologics)
Key Partnerships:Nine Continents Medical (INTIBIA device co-development), Various wound care institutions and research centers
COMPETITION
Position:Leader
Competitors:ConvaTec (closest competitor), Hollister Incorporated, 3M, B. Braun Melsungen AG, Smith & Nephew, Mölnlycke Health Care AB, Organogenesis Inc., Johnson & Johnson +2 more
LEADERSHIP
Key Executives:
Lars Søren Rasmussen - Chairman (interim CEO as of May 2025)
Anders Lonning-Skovgaard - Executive Vice President & CFO
Nicolai Buhl - Executive Vice President, Chronic Care
Caroline Vagner Rosenstand - Executive Vice President, Voice & Respiratory Care
Thomas Johns Jr. - Executive Vice President, Interventional Urology
Scientific Founders:Aage Louis-Hansen (Coloplast founder, 1957)
Board Members:Lars Søren Rasmussen (Chairman), Niels Peter Louis-Hansen (Deputy Chairman), Annette Brüls (Board Member), Carsten Hellmann (Board Member), Jette Nygaard-Andersen (Board Member), Marianne Wiinholt (Board Member), Thomas Barfod (Employee-elected Board Member), Nikolaj Kyhe Gundersen (Employee-elected Board Member), Roland Vendelbo Pedersen (Employee-elected Board Member)
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Coloplast (Coloplast Manufacturing France). The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.